SCHEMBL56276

SCHEMBL56276

CC(C)[C@@H](C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3609 1.00
SCHEMBL56475 1.00
Fluoride SCHEMBL25337975 0.94
Isopropylamine SCHEMBL8103474 0.94 ALDH1A1 (0.40)
Hydrochloric Acid SCHEMBL6267532 0.94
Hydrochloric Acid SCHEMBL4917263 0.94
Hydrochloric Acid SCHEMBL5741254 0.94
Hydrochloric Acid SCHEMBL4919255 0.94
SCHEMBL10768974 0.85 ALDH1A1 (0.33)
SCHEMBL8133423 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12104106-B2 Compositions of chiral molecules and perovskite nanocrystals and methods of making the same ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2024-10-01 US claimed
US-20230033510-A1 Compounds and Methods for Treatment of Visceral Pain ARENA PHARMACEUTICALS, INC. 2023-02-02 US claimed
CN-115304729-A High-crystallinity chiral two-dimensional covalent organic framework material and preparation method thereof 中国科学院化学研究所 2022-11-08 CN claimed
CN-109071554-B Pyrazolo [1,5-a ] pyrimidine compounds 卫材R&D管理有限公司 2021-03-16 CN claimed
US-20210060040-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2021-03-04 US claimed
US-10632134-B2 Cannabinoid receptor modulators ARENA PHARMACEUTICALS, INC. (US) 2020-04-28 US claimed
US-20200078358-A1 Compounds and Methods for Treatment of Visceral Pain ARENA PHARMACEUTICALS, INC. 2020-03-12 US claimed
CN-110709085-A Compounds and methods for treating visceral pain 艾尼纳制药公司 2020-01-17 CN claimed
CN-109970708-A Cannibinoid receptor modulators 艾尼纳制药公司 2019-07-05 CN claimed
CN-103492369-B Cannabinoid receptor modulators 艾尼纳制药公司 2019-03-29 CN claimed
US-20090069581-A1 PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-03-12 US claimed
WO-2008151170-A2 PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2008-12-11 WO claimed
EP-1397364-B1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS LILLY CO ELI (US) 2007-07-25 EP claimed
US-20060135538-A1 7-(R)-aminotriazolopyrimidines, their preparation and their use for controlling phytopathogenic fungi BLASCO JORDI TORMO I 2006-06-22 US claimed
US-6855718-B2 7-(r)-aminotriazolopyrimidines, the production thereof and use of the same for combatting phytopathogenic fungi BASF AKTIENGESELLSCHAFT (DE) 2005-02-15 US claimed
US-20040110771-A1 7-(r)-aminotriazolopyrimidines, the production thereof and use of the same for combatting phytopathogenic fungi BASF AKTIENGESELLSCHAFT (DE) 2004-06-10 US claimed
EP-1397364-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2004-03-17 EP claimed
EP-1368351-A2 7-(R)-AMINO-TRIAZOLOPYRIMIDINES, THE PRODUCTION THEREOF AND USE OF THE SAME FOR COMBATING PHYTOPATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2003-12-10 EP claimed
WO-2002094833-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2002-11-28 WO claimed
WO-2002038565-A2 7-(R)-AMINO-TRIAZOLOPYRIMIDINES, THE PRODUCTION THEREOF AND USE OF THE SAME FOR COMBATING PHYTOPATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2002-05-16 WO claimed